Shop
Vitamin K was discovered in 1936 as a clotting factor. Over the past 80 years it has evolved into a subject of great interest in the scientific community due to its astonishing health benefits. Among its two biologically active forms, K1 (Phylloquinone) and K2 (Menaquinone), it’s the latter that has garnered attention for its versatile roles beyond just blood clotting. Both K1 and K2 work by carboxylating vitamin K-dependent proteins (VKPDs). These carboxylated VKPDs help regulate calcium. The make sure that calcium goes to where it should, like bones, and avoids places it shouldn’t, such as soft tissues and vascular walls. Here, we delve into the fascinating world of Vitamin K2-7, its health benefits, and groundbreaking research findings.
Health Benefits of Vitamin K2-7
Extensive research has revealed a broad range of health benefits associated with Vitamin K2-7. From energy regulation (VO2 max) to peripheral neuropathy and muscle cramps, this vitamin has shown promise in diverse areas. Recent studies have even explored its potential role in mitigating COVID-19 morbidity and mortality. It’s worth noting that Vitamin K2-7 plays a pivotal role in mitochondrial ATP generation. It is acting as a key component in the mitochondrial electron transport chain.
This vitamin has also been explored as a solution for various ailments, including chronic venous insufficiency, post-thrombotic syndrome, skin conditions related to melanization, hyperpigmentation, paresthesia, edema, varicose veins, and cramps. In addition, it has demonstrated an ability to enhance blood perfusion and alleviate hypoxia.
Another promising application is in addressing residual neuropathy. Even when patients receive treatments such as vitamin B12 supplementation or maintain good glycemic control in diabetes, neuropathy symptoms often persist. Vitamin K2-7 has shown potential in alleviating these residual neuropathy symptoms.
Vitamin K2-7 in Peripheral Neuropathy: Clinical Evidence
Clinical studies have provided strong support for the use of Vitamin K2-7 in peripheral neuropathy. Particularly in cases related to vitamin B12 deficiency or diabetes. Patients supplemented with K2-7 exhibited significant reductions in symptoms, including tingling, numbness, fatigue, and cramps. Importantly, these studies also underscored the safety and tolerability of Vitamin K2-7 supplementation.
Randomized placebo-controlled double-blind studies confirmed that the improvements seen were indeed due to Vitamin K2-7. Additionally, measurements of the levels of this vitamin in patients correlated with clinical responses, further supporting its role in alleviating neuropathy symptoms.
At a molecular level, this vitamin appears to modulate various signal transduction pathways implicated in neuropathic pain. One significant pathway involves the Gas6/TAM signaling. This pathway promotes the repair and synthesis of myelin in the peripheral nervous system, which is often damaged in neuropathy.
Inflammatory pathways play a substantial role in neuropathic pain, with proinflammatory cytokines like TNF-α and IL-1β being upregulated in affected tissues. Vitamin K2-7, however, seems to downregulate these cytokines, potentially reducing inflammation and pain.
Chemokine signaling, particularly through CXCR4/NLRP3 inflammasome, has also been implicated in neuropathic pain. Vitamin K2-7 could have a role in modulating this pathway, providing another layer of pain relief.
MicroRNAs in Neuropathic Pain
MicroRNAs, small RNA molecules that regulate gene expression, play a crucial role in neuropathic pain. In neuropathy, specific microRNAs are either upregulated or downregulated, contributing to pain symptoms. These microRNAs could serve as potential diagnostic and therapeutic targets for neuropathic pain.
Conclusion
Peripheral neuropathy, a condition with a wide range of causes, can significantly affect the quality of life due to its debilitating symptoms. Vitamin K2-7 has emerged as a promising intervention, showcasing its potential to alleviate neuropathy symptoms, particularly in cases related to vitamin B12 deficiency or diabetes.
At the molecular level, Vitamin K2-7 seems to modulate various pathways implicated in neuropathic pain, offering potential mechanisms for its therapeutic effects. Additionally, microRNAs, which play a vital role in gene regulation, could serve as diagnostic markers and targets for neuropathic pain management.
The implications of these findings are profound. Vitamin K2-7 could be a game-changer in neuropathy management, providing relief to millions of individuals suffering from this challenging condition. This is an exciting area of research with promising potential for the future of neuropathy treatment.
Source: